Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Viral Replication: Lytic Cycle01:20

Viral Replication: Lytic Cycle

243
Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
243
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

46.8K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.8K
Viral Replication: Lysogenic Cycle01:16

Viral Replication: Lysogenic Cycle

230
The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
230
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

5.3K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.3K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.4K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.4K
Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

71.9K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
71.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microbiological and rheological dynamics of mixed biofilms formed by bacteria and eukaryotic virus.

Scientific reports·2026
Same author

[Reoviruses: from replication cycle to oncolytic activity].

Virologie (Montrouge, France)·2025
Same author

The reovirus μ2 protein, an enigmatic multifunctional protein with numerous secrets yet to be uncovered.

Virology·2024
Same author

Emerging reoviruses: the next pandemic?

Virologie (Montrouge, France)·2023
Same author

[Emerging reoviruses: the next pandemic?]

Virologie (Montrouge, France)·2023
Same author

Reovirus μ2 Protein Impairs Translation to Reduce U5 snRNP Protein Levels.

International journal of molecular sciences·2023

Related Experiment Video

Updated: Sep 11, 2025

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

9.2K

Reoviruses : from replication cycle to oncolytic activity.

Guy Lemay

    Virologie (Montrouge, France)
    |August 18, 2025
    PubMed
    Summary

    Mammalian reovirus is a naturally oncolytic virus that preferentially destroys cancer cells without genetic modification. This review explores its replication cycle and strategies to enhance its anticancer virotherapy potential.

    Area of Science:

    • Oncology
    • Virology
    • Biotechnology

    Background:

    • Mammalian reovirus exhibits natural oncolytic properties, selectively targeting transformed cells.
    • Observations since the 1970s indicate its potential for cancer treatment.
    • Research in the late 1990s solidified the concept of reovirus-based anticancer virotherapy.

    Purpose of the Study:

    • To review the viral replication cycle relevant to oncolytic activity.
    • To discuss strategies for optimizing reovirus efficacy in cancer therapy.

    Main Methods:

    • Literature review of reovirus replication and oncolytic potential.
    • Analysis of existing research on reovirus-based virotherapy.

    Main Results:

    Keywords:
    oncolytic virusesreovirus

    More Related Videos

    Handling of the Cotton Rat in Studies for the Pre-clinical Evaluation of Oncolytic Viruses
    06:13

    Handling of the Cotton Rat in Studies for the Pre-clinical Evaluation of Oncolytic Viruses

    Published on: November 24, 2014

    9.4K
    Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
    12:42

    Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

    Published on: January 7, 2019

    9.6K

    Related Experiment Videos

    Last Updated: Sep 11, 2025

    Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
    08:51

    Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

    Published on: April 3, 2018

    9.2K
    Handling of the Cotton Rat in Studies for the Pre-clinical Evaluation of Oncolytic Viruses
    06:13

    Handling of the Cotton Rat in Studies for the Pre-clinical Evaluation of Oncolytic Viruses

    Published on: November 24, 2014

    9.4K
    Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
    12:42

    Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

    Published on: January 7, 2019

    9.6K
  • Reovirus naturally targets and lyses cancer cells.
  • Its replication cycle is key to its oncolytic mechanism.
  • Optimization strategies can enhance its therapeutic effectiveness.

    • Conclusions:

    • Mammalian reovirus is a promising naturally oncolytic agent.
    • Understanding its replication cycle is crucial for virotherapy development.
    • Further research into optimization strategies can improve its clinical application.